Papers 11–20 of
20
by Patrick D McMullen
- ME Andersen, PD McMullen, MB Phillips, M Yoon, SN Pendse, HJ Clewell, JK Hartman, M Moreau, RA Becker, and RA Clewell. Developing context appropriate toxicity testing approaches using new alternative methods (NAMs). ALTEX 36 (4) : 523-534 (Jan 1, 2019). [abstract] [pubmed]
- S Haider, MB Black, BB Parks, B Foley, BA Wetmore, ME Andersen, RA Clewell, K Mansouri, and PD McMullen. A Qualitative Modeling Approach for Whole Genome Prediction Using High-Throughput Toxicogenomics Data and Pathway-Based Validation. Front Pharmacol 9 : 1072 (Oct 2, 2018). [abstract] [pubmed]
- JK Hartman, T Beames, B Parks, D Doheny, G Song, M Yoon, B Foley, C Deisenroth, PD McMullen, RA Clewell, and AY Efremenko. An in vitro approach for prioritization and evaluation of chemical effects on glucocorticoid receptor mediated adipogenesis. Toxicol Appl Pharmacol 355 : 112-126 (Sep 15, 2018). [abstract] [pubmed]
- ME Andersen, G Cruzan, MB Black, SN Pendse, DE Dodd, JS Bus, SS Sarang, MI Banton, R Waites, DB Layko, and PD McMullen. Strain-related differences in mouse lung gene expression over a two-year period of inhalation exposure to styrene: Relevance to human risk assessment. Regul Toxicol Pharmacol 96 : 153-166 (Jul 17, 2018). [abstract] [pubmed]
- R Buesen, BN Chorley, B da Silva Lima, G Daston, L Deferme, T Ebbels, TW Gant, A Goetz, J Greally, L Gribaldo, J Hackermüller, B Hubesch, D Jennen, K Johnson, J Kanno, HM Kauffmann, M Laffont, R Meehan, M Pemberton, S Perdichizzi, AH Piersma, UG Sauer, K Schmidt, H Seitz, K Sumida, KE Tollefsen, W Tong, T Tralau, B van Ravenzwaay, RJM Weber, A Worth, C Yauk, A Poole, and PD McMullen. Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop. Regul Toxicol Pharmacol 91 Suppl 1 : S3-S13 (Dec 25, 2017). [abstract] [pubmed]
- ME Andersen, G Cruzan, MB Black, SN Pendse, D Dodd, JS Bus, SS Sarang, MI Banton, R Waites, and PD McMullen. Assessing molecular initiating events (MIEs), key events (KEs) and modulating factors (MFs) for styrene responses in mouse lungs using whole genome gene expression profiling following 1-day and multi-week exposures. Toxicol Appl Pharmacol 335 : 28-40 (Nov 15, 2017). [abstract] [pubmed]
- ME Andersen, MB Black, JL Campbell, SN Pendse, HJ Clewell, LH Pottenger, JS Bus, DE Dodd, DC Kemp, and PD McMullen. Combining transcriptomics and PBPK modeling indicates a primary role of hypoxia and altered circadian signaling in dichloromethane carcinogenicity in mouse lung and liver. Toxicol Appl Pharmacol 332 : 149-158 (Oct 1, 2017). [abstract] [pubmed]
- MM Miller, PD McMullen, ME Andersen, and RA Clewell. Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts. Crit Rev Toxicol 47 (7) : 564-580 (Aug 4, 2017). [abstract] [pubmed]
- SN Pendse, A Maertens, M Rosenberg, D Roy, RA Fasani, MM Vantangoli, SJ Madnick, K Boekelheide, AJ Fornace, SA Odwin, JD Yager, T Hartung, ME Andersen, and PD McMullen. Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity. Arch Toxicol 91 (4) : 1749-1762 (Apr 3, 2017). [abstract] [pubmed]
- RA Clewell, PD McMullen, Y Adeleye, PL Carmichael, and ME Andersen. Pathway Based Toxicology and Fit-for-Purpose Assays. Adv Exp Med Biol 856 : 205-230 (Jan 1, 2016). [abstract] [pubmed]